Draft Agenda


Home   |   Background  |   Agenda   |   ACHRE Alumni (password)


achre-titlecropped5


Agenda – October 5, 2016


10:30 -11:00    Opening Remarks

Ruth Faden, PhD, MPH
Founder, Johns Hopkins Berman Institute of Bioethics, Director 1995-2016, and inaugural Andreas C. Dracopoulos Director, 2014-2016.  Currently Philip Franklin Wagley Professor of Medical Ethics, Johns Hopkins Berman Institute of Bioethics

11:00-11:50     Secrecy, Science, and National Security

Anna Mastroianni, JD, MPH (Moderator)
Professor of Law, University of Washington, School of Law and Institute for Public Health Genetics

Jonathan Moreno, PhD
David and Lyn Silfen University Professor of Ethics, University of Pennsylvania

Dan Guttman, JD
Teacher, Consultant, Author, Shanghai, China

Philip K. Russell, PhD, MD
Former Commander, US Army Medical Research and Development Command Professor Emeritus, Dept. of International Health, Johns Hopkins Bloomberg School of Public Health

1:50-12:05       Break

12:05-1:00       Informed Consent, Then and Now

Eli Glatstein, MD (Moderator)
Professor Emeritus in Radiation Oncology, University of Pennsylvania

Henry Royal, MD
Professor of Radiology, Washington University School of Medicine, Associate Director of Nuclear Medicine, Mallinckrodt Institute of Radiology

Jeremy Sugarman, MD, MPH, MA
Harvey M. Meyerhoff Professor of Bioethics and Medicine, Johns Hopkins Berman Institute of Bioethics

Nancy Kass, ScD
Phoebe R. Berman Professor of Bioethics and Public Health, Johns Hopkins Berman Institute of Bioethics

1:00-2:00         Lunch

2:00-2:50         Remedies: Population Risk and Government Wrongdoing

Duncan Thomas, PhD (Moderator)
Professor of Biostatistics, Department of Preventive Medicine, and Verna Richter Chair in Cancer Research at the University of Southern California

Ken Feinberg, JD
The Law Offices of Kenneth R. Feinberg, PC

Jeffrey Kahn, PhD, MPH
Andreas C. Dracopoulos Director, Johns Hopkins Berman Institute of Bioethics, Johns Hopkins Berman Institute of Bioethics

Reed Tuckson, MD
Managing Director of Tuckson Health Connections, LLC

3:00-4:00         The Challenge and Value of Historical Events

Nancy Oleinick, PhD (Moderator)
Professor of Radiation Oncology, and Joseph T. Wearn, MD, University Professor of Medicine, Case Western Reserve University

Patricia King, JD
Carmack Waterhouse Professor of Law, Medicine, Ethics and Public Policy Georgetown University Law Center

Ruth Macklin, PhD
Distinguished University Professor Emerita, Albert Einstein College of Medicine

Susan Lederer, PhD
Robert Turell Professor of History of Medicine and Bioethics, Department of Medical History and Bioethics, University of Wisconsin School of Medicine and Public Health

4:00-4:30         Wrap up and Concluding Comments:

Ruth Faden, PhD, MPH
Founder, Johns Hopkins Berman Institute of Bioethics, Director 1995-2016, and inaugural Andreas C. Dracopoulos Director, 2014-2016.  Currently Philip Franklin Wagley Professor of Medical Ethics, Johns Hopkins Berman Institute of Bioethics


Moderator & Panelist Biosketches


Ruth R. Faden, PhD, MPH is the founder of the Johns Hopkins Berman Institute of Bioethics. She was the Berman Institute’s Director from 1995 until 2016, and the inaugural Andreas C. Dracopoulos Director (2014-2016). Dr. Faden was, and is currently, the inaugural Philip Franklin Wagley Professor of Biomedical Ethics. In the twenty years in which Dr. Faden led the Institute, she transformed what was an informal interest group of Hopkins faculty into one of the leading and largest bioethics programs in the world. Dr. Faden is also a prolific scholar, author and editor of numerous books and many articles on biomedical ethics and public policy, including most significantly Social Justice: The Moral Foundations of Public Health and Health Policy (with Madison Powers) and A History and Theory of Informed Consent (with Tom L. Beauchamp). With Madison Powers, Dr. Faden’s current book project is tentatively titled: Structural Injustice: Deprivation, Disadvantage and Domination.

Kenneth R. Feinberg, JD is one of the nation’s leading experts in alternative dispute resolution, serving as Administrator for OneOrlando, The 9/11 Victim Compensation Fund, TARP Executive Compensation, and the Agent Orange Victim Compensation Program. In 2010, Mr. Feinberg was appointed by the Obama Administration to administer a fund to compensate victims of the BP oil spill in the Gulf of Mexico.  Most recently, Mr. Feinberg served as Administrator of the GM Ignition Switch Program and the One Fund Boston Victim Relief Fund established to benefit the victims of the Boston Marathon attacks of April 15, 2013.

Eli Glatstein, MD is a well-known radiation oncologist, presently Professor Emeritus in Radiation Oncology at the University of Pennsylvania.  Educated at the University of Iowa, and at Stanford Medical School, he graduated in 1964, then interned at New York Hospital. In 1965 he was drafted into the US Army for 2 years, one of which was spent in the Republic of South Vietnam where he was awarded a Bronze Star.  He returned to Stanford for his residency in Radiation Oncology and later did 2 years of radiobiology work at the Gray Lab in London before returning to the Stanford faculty in 1972.

In 1977, he became the Chief of Radiation Oncology at the National Cancer Institute in Bethesda, MD where he spent the next 15 years. Following a 4 year stint as the Chief of Radiation Oncology at the UT Southwestern Medical School in Dallas, he went to University of Pennsylvania where he has been on the faculty for the last 20 years.

Dan Guttman, JD is a teacher, lawyer and has been a public servant.  He was special counsel to Senate investigations of government management, ACHRE Executive Director, US Occupational Safety and Health Review Commission Commissioner, and is UNDP advisor on China environmental law implementation. He has represented workers, whistleblowers, and governments in litigation leading to Congressional enactment of asbestos in schools and nuclear worker compensation laws, government recovery of hundreds of millions from oil companies and military contractors, application of antimonopoly principles to the electric industry, and the DC Human rights act to workers.  Since going to China in 2004 as Fulbright, he has been teaching in universities in Beijing, Shanghai and Nanjing and working with colleagues developing programs in law, environment, and China/US relations. He is co-author/author of many books/articles including The Shadow Government, a seminal study of the contracting out of US government, shared in journalism awards, and is board member of Shanghai Roots and Shoots, an NGO working with 400 schools and thousands of volunteers in environmental and humanitarian projects.

His expertise is primarily in lymphoma, sarcoma and lung cancer, and is well-known for developing combined modality efforts of treatment.  For decades he has focused on photodynamic therapy for the treatment of mesothelioma and selected lung cancer problems. He has also been heavily involved in randomized clinical trials at multiple sites. His main legacy is that he has trained and/or mentored junior faculty into 29 chairmanships in academic departments of radiation oncology in the United States, plus 2 in Europe and 2 in Israel.

Jeffrey Kahn, PhD, MPH is the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics.  He is also Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy, and Professor in the Department of Health Policy and Management in the Johns Hopkins University Bloomberg School of Public Health.  His research interests include the ethics of research, ethics and public health, and ethics and emerging biomedical technologies.  He speaks widely both in the U.S. and abroad, and has published four books and over 125 articles in the bioethics and medical literature.  He is an elected Fellow of the Hastings Center, and has chaired or served on committees and panels for the National Institutes of Health, the Centers for Disease Control, and the Institute of Medicine/National Academy of Medicine, where he is currently chair of the Board on Health Sciences Policy.  His education includes a BA in microbiology (UCLA, 1983), MPH (Johns Hopkins, 1988), and PhD in philosophy (Georgetown, 1989).

Nancy Kass, ScD is the Phoebe R. Berman Professor of Bioethics and Public Health at Johns Hopkins, Deputy Director for Public Health in the Berman Institute of Bioethics, and Professor in the JHU Bloomberg School of Public Health.  In 2009-2010, Dr. Kass was based in Geneva, Switzerland, working with the World Health Organization (WHO) Ethics Review Committee Secretariat. Current research examines informed consent in randomized trials, ethics in international health research, ethical guidance development for infectious outbreaks, and ethics and learning health care.  Dr. Kass directed the School’s PhD program in bioethics and health policy from its inception until 2016, and she directs the Johns Hopkins Fogarty African Bioethics Training Program.  She served as consultant to the President’s Advisory Committee on Human Radiation Experiments, the National Bioethics Advisory Commission, and the National Academy of Sciences.  Dr. Kass is an elected member of the Institute of Medicine and elected Fellow of the Hastings Center.

Patricia King, JD Professor King’s expertise is in the study of law, medicine, ethics and public policy. She is also an adjunct professor in the Department of Health Policy and Management, School of Hygiene and Public Health at Johns Hopkins University. She is the co-author of Cases and Materials on Law, Science and Medicine. She teaches Family Law courses and offers a seminar in Bioethics and the Law. She is a member of the American Law Institute and the Institute of Medicine and a Fellow of the Hastings Center. Her work in the field of bioethics has included service on the HEW-Advisory Recombinant DNA Advisory Committee, the President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, and the Ethics, Legal and Social Issues Working Group of the Human Genome Project. She is a fellow of the Harvard Corporation and a member of the Board of Trustees of Wheaton College. Her professional experience before joining the Law Center faculty in 1973 was primarily in the civil rights field; she was the Deputy Director of the Office of Civil Rights and Special Assistant to the Chairman of the EEOC. She also served as a Deputy Assistant Attorney General in the Civil Division of the Department of Justice.

Susan E. Lederer, PhD is the Robert Turell Professor of the History of Medicine and Bioethics at the University of Wisconsin School of Medicine and Public Health. In January 2008 she was appointed Chair of the Department of Medical History and Bioethics.  A historian of medicine and biomedical ethics, she received her doctorate in the history of science and medicine at the University of Wisconsin Madison.  She has taught in the Department of Humanities at the Pennsylvania State University College of Medicine and in the Section of Medical History at Yale University School of Medicine before coming to Madison.  She has published extensively on the history of both human and animal experimentation. In addition to ACHRE, she also served on presidential commissions for the German government, charged with exploring the conduct of human experimentation during the period of National Socialism.  Her books include Subjected to Science: Human Experimentation in America Before the Second World War (Johns Hopkins University Press, 1995); Frankenstein: Penetrating the Secrets of Nature (Rutgers University Press, 2002), and Flesh and Blood: A Cultural History of Transplantation and Transfusion in Twentieth-Century America (Oxford University Press, 2008).  She is currently writing a biography of Dr. Henry K. Beecher.

Ruth Macklin, MA, PhD is Distinguished University Professor Emerita (Bioethics) at Albert Einstein College of Medicine in the Bronx, New York.  She received a BA with Distinction from Cornell University and an MA and PhD in Philosophy from Case Western Reserve University. She has more than two hundred sixty publications in professional journals and scholarly books in bioethics, law, medicine, philosophy, and the social sciences, in addition to articles in magazines and newspapers for general audiences. She is author or editor of thirteen books, including Against Relativism (1999), Double Standards in Medical Research in Developing Countries (2004), and Ethics in Global Health:  Research, Policy and Practice (2012). Dr. Macklin is an elected member of the National Academy of Medicine (US) and serves as a consultant to the World Health Organization.

Jonathan D. Moreno, PhD is the David and Lyn Silfen University Professor at the University of Pennsylvania where he is a Penn Integrates Knowledge (PIK) professor. At Penn he is also Professor of Medical Ethics and Health Policy, of History and Sociology of Science, and of Philosophy.

His latest book is Impromptu Man: J.L. Moreno and the Origins of Psychodrama, Encounter Culture, and the Social Network (2014), which Amazon called a “#1 hot new release.”  Among his previous books are The Body Politic, which was named a Best Book of 2011 by Kirkus Reviews, Mind Wars (2012), and Undue Risk (2000).  He has published hundreds of papers, articles, reviews and op-eds.

Moreno frequently contributes to such publications as The New York Times, The Wall Street Journal, The Huffington Post, Psychology Today, and Nature and often appears on broadcast and online media. In 2008-09 he served as a member of President Barack Obama’s transition team.  His work has been cited by Al Gore and was used in the development of the screenplay for “The Bourne Legacy.”  His online neuroethics course drew more than 36,000 registrants in fall 2013.  The American Journal of Bioethics has called him “the most interesting bioethicist of our time.”

Moreno is an elected member of the National Academy of Medicine and is the U.S. member of the UNESCO International Bioethics Committee.  A Senior Fellow at the Center for American Progress in Washington, D.C., Moreno has served as an adviser to many governmental and non-governmental organizations, including three presidential commissions, the Department of Defense, the Department of Homeland Security, the Department of Health and Human Services, the Centers for Disease Control, the Federal Bureau of Investigation, the Howard Hughes Medical Institute, and the Bill and Melinda Gates Foundation.  He holds the Visiting Professorship in History at the University of Kent in Canterbury, England.  Moreno’s writings have been translated into Chinese, German, Japanese and Portuguese.

Moreno received his PhD in philosophy from Washington University in St. Louis, was an Andrew W. Mellon post-doctoral fellow, holds an honorary doctorate from Hofstra University, and is a recipient of the Benjamin Rush Medal from the College of William and Mary Law School, the Dr. Jean Mayer Award for Global Citizenship from Tufts University, and the Penn Alumni Faculty Award of Merit.

Nancy L. Oleinick, PhD earned her BS in chemistry from Chatham College and her PhD in biochemistry from the University of Pittsburgh followed by post-doctoral research at Case Western Reserve University (CWRU).  At CWRU, she is currently professor of radiation oncology, biochemistry, oncology and environmental health sciences and the Joseph T. Wearn, M.D., University Professor of Medicine.  Her research specializes in radiosensitization and photosensitization of cancer cells.  She has published over 175 papers on these topics and worked with physicians to bring novel sensitizing drugs into clinical trials.   Nancy has served on several journal editorial boards and on four NIH study sections reviewing grant applications in radiobiology, photobiology, oxidative stress, and cancer research.  She was president of the American Society for Photobiology and has been a member of several review panels considering radiation effects and carcinogenesis, including the Advisory Committee on Human Radiation Experiments, the National Academy of Sciences’ Committee on the Biological Effects of Ionizing Radiation, Phase I, and the Veterans Advisory Committee on Environmental Hazards.

 

Henry Royal, MD is a professor of radiology at Washington University School of Medicine in St. Louis, MO and the Associate Director of Nuclear Medicine at the Mallinckrodt Institute of Radiology.  He did his Internal Medicine training at Brown University in Providence RI and his nuclear medicine training at Harvard University in Boston, MA.  He was a member of the American Board of Nuclear Medicine from 1993 to 1999 and served as its executive director from 2004 to 2014. He was president of the Society of Nuclear Medicine from 2003 to 2004.

He was the co-team leader of the health effects section of the IAEA’s International Chernobyl Project and a member of the Presidential Advisory Committee on Human Radiation Experiments.  He has been a member of several National Academy of Sciences committees. He also was a member of the Board of Directors of the National Council on Radiation Protection and Measurements from 2000-2005. He was a member of the US delegation to the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) from 2002 to 2005.

He was the scientific chair of the Veterans’ Advisory Committee on Environmental Hazards from 2001 to 2010. He is currently serving on the National Academy of Sciences’ Nuclear and Radiation Sciences Board.

Philip K. Russell, PhD, MD Retired Major General Philip Russell served in the U.S. Army Medical Corps from 1969 to 1990 pursuing a career in infectious disease and tropical medicine research. Following training in internal medicine his military assignments included several overseas assignments, director of Walter Reed Army Institute, commander of Fitzsimons Army Medical Center, and commander of the U.S, Army Medical Research and Development Command.  He contributed to the development of several vaccines including adenovirus, meningitis, hepatitis A, dengue and malaria vaccines.

Following his military career he joined Johns Hopkins University School of Public Health as professor of international health.  In 2001 after the anthrax attacks, he led the DHHS effort to develop and stockpile vaccines and other medical countermeasures against bioterrorism. Russell has served on numerous advisory boards of national and international public health organizations.  He has served on the board of directors of IAVI, AERAS, IVI and the Sabin Vaccine Institute.

Jeremy Sugarman, MD, MPH, MA is the Harvey M. Meyerhoff Professor of Bioethics and Medicine, professor of medicine, professor of Health Policy and Management, and deputy director for medicine of the Berman Institute of Bioethics at the Johns Hopkins University. He is an internationally recognized leader in the field of biomedical ethics with particular expertise in applying empirical methods and evidence-based standards for evaluating and analyzing bioethical issues. His contributions to both medical ethics and policy include his work on the ethics of informed consent, umbilical cord blood banking, stem cell research, international HIV prevention research, global health and research oversight.

Dr. Sugarman is the author of approximately 300 articles, reviews and book chapters.  He is an elected member of the American Society of Clinical Investigation, Association of American Physicians, and the Institute of Medicine. He is a fellow of the American Association for the Advancement of Science, the American College of Physicians and the Hastings Center.

Duncan Thomas, PhD is Professor of Biostatistics in the Department of Preventive Medicine and holds the Verna Richter Chair in Cancer Research at the University of Southern California.  He received his PhD in epidemiology from McGill University in 1976, where he continued as a faculty member until his recruitment to USC in 1984.  His primary research interest has been in the development of statistical methods for environmental and genetic epidemiology.  On the environmental side, he has been particularly active in radiation and air pollution research and served as a member of President Clinton’s Advisory Committee on Human Radiation Experiments.  On the genetic side, he was past President of the International Genetic Epidemiology Society.  Dr. Thomas has numerous publications in both areas, including two textbooks on statistical methods in epidemiology.

Reed V. Tuckson, MD, FACP is Managing Director of Tuckson Health Connections, LLC, a health and medical care consulting business that brings people and ideas together to promote optimal health outcomes and value through innovation and integration across the fields of prevention; public health; consumer activation; quality care delivery; the translation of science and technology into value producing interventions; and optimization of big data and analytics.

Previously, Dr. Tuckson served as Executive Vice President and Chief of Medical Affairs for UnitedHealth Group; Senior Vice President for Professional Standards of the AMA; Senior Vice President of the March of Dimes Birth Defects Foundation; President of the Charles R. Drew University of Medicine and Science; and Commissioner of Public Health for the District of Columbia.

At the National Institutes of Health, Dr. Tuckson currently serves on the Clinical Center Research Hospital Board and the National Advisory Council for Complementary and Integrative Health. He is an elected member of the National Academy of Medicine, currently serving on various Committees.